Intestine and Multivisceral Transplantation: Current Status and Future Directions

Chandrashekhar A. Kubal, Richard S. Mangus, A. Joseph Tector

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations


Intestinal failure and associated parenteral nutrition-induced liver failure cause significant morbidity, mortality, and health care burden. Intestine transplantation is now considered to be the standard of care in patients with intestinal failure who fail intestinal rehabilitation. Intestinal failure-associated liver disease is an important sequela of intestinal failure, caused by parenteral lipids, requiring simultaneous liver-intestine transplant. Lipid minimization and, in recent years, the emergence of fish oil-based lipid emulsions have been shown to reverse parenteral nutrition-associated hyperbilirubinemia, but not fibrosis. Significant progress in surgical techniques and immunosuppression has led to improved outcomes after intestine transplantation. Intestine in varying combination with liver, stomach, and pancreas, also referred to as multivisceral transplantation, is performed for patients with intestinal failure along with liver disease, surgical abdominal catastrophes, neuroendocrine and slow-growing tumors, and complete portomesenteric thrombosis with cirrhosis of the liver. Although acute and chronic rejection are major problems, long-term survivors have excellent quality of life and remain free of parenteral nutrition.

Original languageEnglish (US)
JournalCurrent gastroenterology reports
Issue number1
StatePublished - Jan 2015
Externally publishedYes


  • Acute rejection
  • Chronic rejection
  • Immunosuppression
  • Intestinal failure
  • Intestine transplantation
  • Liver failure
  • Multivisceral transplantation
  • Parenteral nutrition

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Intestine and Multivisceral Transplantation: Current Status and Future Directions'. Together they form a unique fingerprint.

Cite this